Arcus Biosciences Inc (RCUS)

Net profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands -283,000 -270,000 -249,000 -231,000 -307,000 -293,000 -287,000 -279,000 -267,000 79,538 66,563 57,593 53,000 -278,391 -198,594 -167,698 -122,858 -87,603 -111,777 -94,793
Revenue (ttm) US$ in thousands 258,000 263,000 247,000 237,000 117,000 119,355 121,236 118,995 112,000 433,144 408,724 399,137 398,304 53,292 108,361 92,939 77,517 77,780 15,000 15,000
Net profit margin -109.69% -102.66% -100.81% -97.47% -262.39% -245.49% -236.73% -234.46% -238.39% 18.36% 16.29% 14.43% 13.31% -522.39% -183.27% -180.44% -158.49% -112.63% -745.18% -631.95%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-283,000K ÷ $258,000K
= -109.69%

Net profit margin is a crucial financial ratio that reflects the company's profitability by measuring the percentage of net income generated from total revenue. A negative net profit margin indicates that the company is operating at a loss.

Based on the data provided, Arcus Biosciences Inc has shown a consistently negative net profit margin from March 31, 2020, to December 31, 2024. The margin has fluctuated over the periods, reaching its lowest point at -745.18% in June 30, 2020, and its highest positive margin of 18.36% in September 30, 2022.

It is noteworthy that the company managed to achieve positive net profit margins in the latter part of the data series, specifically from December 31, 2021, to December 31, 2022. However, the margins turned negative again from March 31, 2023, to December 31, 2024.

Overall, the net profit margin of Arcus Biosciences Inc has shown a mix of negative and positive trends over the analyzed periods, indicating fluctuations in the company's ability to generate profits from its operations.